Clonal heterogeneity of polymorphic B-cell lymphoproliferative disease, EBV-positive, iatrogenic/immune senescence: implications on pathogenesis and treatment.
Yu-Yan HwangRex Kwok-Him Au-YeungRock Y Y LeungEric TseYok-Lam KwongPublished in: Hematology (Amsterdam, Netherlands) (2022)
The presence of both EBV+ and EBV- lesions, which showed different mutational profiles, indicated clonal heterogeneity that might be of biologic and therapeutic significance.